article thumbnail

At Long Last, FDA Unveils Plan for Rare Disease Innovation Hub

FDA Law Blog: Biosimilars

In December 2023, FDA established the Genetic Metabolic Diseases Advisory Committee (also called “GeMDAC,” which we blogged about here ) to advise FDA regarding treatments for genetic metabolic diseases (i.e., clinical pharmacology/biomarkers, animal models, real-world evidence and other externally controlled comparisons [e.g.,

article thumbnail

Episode 782: Wernicke’s Encephalopathy Treatment During an IV Thiamine Shortage

Pharmacy Joe

However, a study published in 2012 in BMC Clinical Pharmacology challenges that concept and seems to show that at very high doses there must be some form of passive, non-saturable absorption of thiamine. Healthy subjects were given oral thiamine at doses of 100 mg, 500 mg, and 1500 mg.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Episode 573: Ceiling dose of ketorolac for renal colic in the ED

Pharmacy Joe

In 1989, a study in the Journal of Clinical Pharmacology compared 10, 30, and 90 mg of IM ketorolac with placebo in 126 patients with cancer pain. While all doses were more effective than placebo, there was no difference in effectiveness between 10, 30, or 90 mg of IM ketorolac.

article thumbnail

Episode 782: Wernicke’s Encephalopathy Treatment During an IV Thiamine Shortage

Pharmacy Joe

However, a study published in 2012 in BMC Clinical Pharmacology challenges that concept and seems to show that at very high doses there must be some form of passive, non-saturable absorption of thiamine. Healthy subjects were given oral thiamine at doses of 100 mg, 500 mg, and 1500 mg.

article thumbnail

7. Reflections on a Career in Pharmacy and Medicine with Dr. Steven Berk

The Physician Pharmacist

⚡️ For more resources to get started, check out some of our other blog post content! And so yeah, I'm the founding lecturer and basic clinical pharmacology to this PA program. I developed and implemented a whole course in clinical pharmacology 24 lectures, each lectures two and a half hours and exams and it was a lot of fun.

article thumbnail

NHC Comments on Landmark FDA Guidance for Diversity in Clinical Trials

Putting Patients First Blog

Clinical Pharmacology & Therapeutics , 97(3) , 263–273. Participation of women in clinical trials supporting FDA approval of cardiovascular drugs. Pacanowski, M., and Zhang, L. Racial/ethnic differences in drug disposition and response: Review of recently approved drugs. 8 Scott, P., Jenkins, M., Southworth, M.,

article thumbnail

FDA Issues “Cliffs Notes”-style Guidance on Cell and Gene Therapy; What Questions Did They Answer? (Part 1)

FDA Law Blog: Biosimilars

The draft guidance includes FAQs covering topics from across disciplines: regulatory review; chemistry, manufacturing, and controls (CMC); nonclinical and pharmacology/toxicology (PT); clinical; and clinical pharmacology. Stay tuned for the next iteration of the Cliffs Notes to the Cliffs Notes.